{"news_desk": "Business", "print_page": "5", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By MICHAEL J. de la MERCED", "person": [{"middlename": "J.", "firstname": "Michael", "lastname": "de la MERCED", "rank": 1, "role": "reported", "organization": ""}]}, "abstract": "DealBook Online; Mallinckrodt Pharmaceuticals says it will buy Ikaria, maker of treatments for critically sick infants, for $2.3 billion.", "type_of_material": "Web Log", "word_count": "173", "lead_paragraph": "Mallinckrodt said that it expected the deal, the latest by a drug maker, to bolster its presence in hospitals.", "pub_date": "2015-03-06T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Mallinckrodt to Buy Drug Maker Ikaria for $2.3 Billion", "print_headline": "Drug Maker Sold"}, "snippet": "Mallinckrodt said that it expected the deal, the latest by a drug maker, to bolster its presence in hospitals.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/03/06/business/dealbook/mallinckrodt-to-buy-drug-maker-ikaria-for-2-3-billion.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Mallinckrodt Pharmaceuticals", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Madison Dearborn Partners", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Pharmacyclics, Incorporated", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Ikaria Inc", "name": "organizations"}], "blog": [], "_id": "54f8611538f0d8579fff63bd", "source": "The New York Times"}